Larotrectinib For Previously Untreated NTRK-fusion Positive Pediatric Solid Tumors and NTRK-fusion Positive Relapsed Pediatric Acute Leukemias

Medicine and Dentistry

1. Acute Leukemia 100%
2. Pediatrics 100%
3. Solid Malignant Neoplasm 100%
4. Fibrosarcoma 50%
5. Cancer 50%
6. Neoplasm 33%
7. Recurrent Disease 33%
8. Clinical Trial 16%
9. Protein Tyrosine Kinase 16%
10. Cancer Cell Line 16%
11. Overall Survival 16%
12. Cell Line 16%
13. Tumor 16%
14. Oral 16%
15. Pathognomonic 16%
16. Event Free Survival 16%